Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.

Frontiers in Pharmacology
Pushpendra GoswamiSam Salek

Abstract

Patients' experience of symptoms often goes undetected during consultation in an outpatient clinic, and the use of a patient-reported outcome measure (PRO) in such a setting could be useful to aid treatment decision-making. A new PRO measure, the HM-PRO (Hematological Malignancy Specific Patient-Reported Outcome Measure) has been recently developed to evaluate hematological malignancy (HM) patients' health-related quality of life (HRQoL) and their symptom experience in daily clinical practice as well as in research. The objectives of the study were to assess: the internal consistency of the scores for Part A (impact) and its four domains (physical behavior; social well-being; emotional behavior; and eating and drinking habits) and Part B (signs and symptoms); and the test-retest reliability of the individual items of the newly developed hematological malignancy specific composite measure, the HM-PRO. This was a prospective longitudinal observational study where 150 patients with different HMs and different stage of disease (male n = 98 (65.3%); mean age 64.9 ± 14.4 years, range 17.9-89.2 years; mean time since diagnosis 3.7 ± 4.9 years, range 0.04-25.8 years) completed the HM-PRO at baseline (assessment 1 at t1) and after 7 day...Continue Reading

References

Feb 6, 2002·European Journal of Cancer Care·L PerssonI R Hallberg
May 7, 2004·European Journal of Haematology·Bernhard HolznerRichard Greil
May 3, 2006·Journal of Psychosomatic Research·Fábio R M SantosJose Roberto Leite
Mar 3, 2007·Cancer·Floortje MolsLonneke V van de Poll-Franse
Sep 28, 2007·British Journal of Haematology·Tait D ShanafeltTimothy G Call
Nov 13, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marlene H FrostUNKNOWN Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group;
Jul 19, 2008·European Journal of Haematology·Kathrin Strasser-Weippl, Heinz Ludwig
Mar 17, 2009·European Journal of Haematology·Anna T JohnsenMogens Groenvold
May 4, 2010·Personality and Social Psychology Review : an Official Journal of the Society for Personality and Social Psychology, Inc·Robert R McCraeAntonio Terracciano
Dec 8, 2015·Hematology·Sarah Dobrozsi, Julie Panepinto
Jun 27, 2011·International Journal of Medical Education·Mohsen Tavakol, Reg Dennick
May 1, 2019·Journal of Comparative Effectiveness Research·Pushpendra GoswamiSam Salek
Oct 27, 2020·Therapeutic Advances in Hematology·Pushpendra GoswamiSam Salek

❮ Previous
Next ❯

Software Mentioned

HM
PRO
Excel
SPSS
MyPOS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.